EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection

Paula Poyatos, Neus Luque, Gladis Sabater, Saioa Eizaguirre, Marc Bonnin, Ramon Orriols, Olga Tura-Ceide

Infection · 2024

DOI: 10.1007/s15010-024-02173-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection, 2024. Verfasst von Paula Poyatos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research …. Hauptthemen laut MEDLINE: COVID-19, Cardiovascular Diseases, SARS-CoV-2. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat de Girona, Instituto de Salud Carlos III, Sociedad Española de Neumología y Cirugía Torácica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

SARS-CoV-2 infection causes severe endothelial damage, an essential step for cardiovascular complications. Endothelial-colony forming cells (ECFCs) act as a biomarker of vascular damage but their role in SARS-CoV-2 remain unclear. The aim of this study was to assess whether the number of ECFCs and angiogenic biomarkers remained altered after 6 and 12-months post-infection and whether this imbalance correlated with the presence of long-COVID syndrome and other biological parameters measured.

Methods

Seventy-two patients were recruited at different time-points after overcoming COVID-19 and thirty-one healthy controls. All subjects were matched for age, gender, BMI, and comorbidities. ECFCs were obtained from peripheral blood and cultured with specific conditions.

Results

The results confirm the presence of a long-term sequela in post-COVID-19 patients, with an abnormal increase in ECFC production compared to controls (82.8% vs . 48.4%, P < 0.01) that is maintained up to 6-months (87.0% vs . 48.4%, P < 0.01) and 12-months post-infection (85.0% vs. 48.4%, P < 0.01). Interestingly, post-COVID-19 patients showed a significant downregulation of angiogenesis-related proteins compared to controls indicating a clear endothelial injury. Troponin, NT-proBNP and ferritin levels, markers of cardiovascular risk and inflammation, remained elevated up to 12-months post-infection. Patients with lower numbers of ECFC exhibited higher levels of inflammatory markers, such as ferritin, suggesting that ECFCs may play a protective role. Additionally, long-COVID syndrome was associated with higher ferritin levels and with female gender.

Conclusions

These findings highlight the presence of vascular sequela that last up to 6- and 12-months post-infection and point out the need for preventive measures and patient follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cardiovascular DiseasesSARS-CoV-2HumansMaleFemaleMiddle AgedEndothelium, VascularAgedAdultBiomarkersEndothelial Progenitor CellsCase-Control StudiesPost-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

Endothelial BiomarkersEndothelial progenitor cellLong-COVIDPost-COVID-19SequelaeVascular injury

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Spain.
  • Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.
  • Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Spain. raorriols.girona.ics@gencat.…
  • Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain. raorriols.girona.ics@gencat.cat.
  • Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Madrid, Spain. raorriols.girona.ics@gencat.cat.
  • Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Spain. olgaturac@gmail.com.

Förderung

  • Universitat de Girona
  • Instituto de Salud Carlos III
  • Sociedad Española de Neumología y Cirugía Torácica
  • Fundació Catalana de Pneumologia
  • Societat Catalana de Pneumologia

Zitieren

APA

Poyatos, P., Luque, N., Sabater, G., Eizaguirre, S., Bonnin, M., Orriols, R., & Tura-Ceide, O. (2024). Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection. Infection. https://doi.org/10.1007/s15010-024-02173-5

Vancouver

Poyatos P, Luque N, Sabater G, Eizaguirre S, Bonnin M, Orriols R, et al. Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection. Infection. 2024. doi:10.1007/s15010-024-02173-5

BibTeX
@article{Poyatos2024,
  author = {Poyatos, Paula and Luque, Neus and Sabater, Gladis and Eizaguirre, Saioa and Bonnin, Marc and Orriols, Ramon and Tura-Ceide, Olga},
  title = {Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection},
  journal = {Infection},
  year = {2024},
  doi = {10.1007/s15010-024-02173-5}
}
Kostenlos starten →